Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Lars Klinge.
Newcastle Authors
Title
Year
Full text
Dr Lars Klinge
Professor Hanns Lochmuller
Mutation Update and Genotype-Phenotype Correlations of Novel and Previously Described Mutations in
TPM2
and
TPM3
Causing Congenital Myopathies
2014
Dr Lars Klinge
Dr Richard Charlton
Dr Steven Laval
Dr Mark Hornsey
Professor Volker Straub
et al.
Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle
2010
Dr Lars Klinge
Dr Michelle Eagle
Dr John Hudson
Dr Anna Sarkozy
Dr Richard Charlton
et al.
New aspects on patients affected by dysferlin deficient muscular dystrophy
2010
Yen-Hui Chiu
Dr Mark Hornsey
Dr Lars Klinge
Dr Louise Jorgensen
Dr Steven Laval
et al.
Attenuated muscle regeneration is a key factor in dysferlin-deficient muscular dystrophy
2009
Dr Steven Laval
Dr Louise Jorgensen
Dr Mark Hornsey
Dr Lars Klinge
Dr Richard Charlton
et al.
Attenuated muscle regeneration is a key factor in dysferlinopathy
2009
Dr Mark Hornsey
Yen-Hui Chiu
Dr Louise Jorgensen
Dr Lars Klinge
Dr Steven Laval
et al.
The evaluation of novel therapeutic strategies for the treatment of dysferlinopathy
2009
Dr Lars Klinge
Dr Steven Laval
Dr Rita Barresi
Professor Hanns Lochmuller
Professor Volker Straub
et al.
G.P.10.05:Preclinical drug trials in vestigating potential treatments for dysferlin deficiency
2008
Dr Lars Klinge
Dr Steven Laval
Dr Mark Hornsey
Yen-Hui Chiu
Professor Volker Straub
et al.
G.P.10.06: Abnormal T-tubule morphology in dysferlin deficient muscle
2008
Dr Lars Klinge
Dr Richard Charlton
Dr Juliane Mueller
Dr Louise VB Anderson
Professor Volker Straub
et al.
Late onset in dysferlinopathy widens the clinical spectrum
2008
Dr Lars Klinge
Dr Richard Charlton
Dr Rita Barresi
Emerita Professor Katherine Bushby
Professor Volker Straub
et al.
Sarcoglycanopathies: Can muscle immunoanalysis predict the genotype?
2008
Dr Lars Klinge
Professor Robin Harris
Dr Richard Charlton
Professor Volker Straub
Dr Rita Barresi
et al.
Dysferlin in muscle regeneration
2007
Dr Lars Klinge
Dr Richard Charlton
Dr Rita Barresi
Emerita Professor Katherine Bushby
Dysferlinopathy with very late onset and untypical clinical presentation
2007
Dr Lars Klinge
Dr Steven Laval
Sharon Foster
Faye Haldane
Professor Volker Straub
et al.
From T-tubule to sarcolemma: Damage-induced dysferlin translocation in early myogenesis
2007
Dr Lars Klinge
Dr Steven Laval
Professor Volker Straub
Dr Rita Barresi
Emerita Professor Katherine Bushby
et al.
Membrane damage induces dysferlin translocation in early myogenesis
2007
Dr Lars Klinge
Dr Steven Laval
Professor Volker Straub
Emerita Professor Katherine Bushby
Damage-induced dysferlin translocation in C2C12 myotubes requires the full length protein
2006
Dr Richard Charlton
Dr Lars Klinge
Emerita Professor Katherine Bushby
Professor Volker Straub
Sarcoglycanopathy - Can immunoanalyses accurately predict the genotype?
2006
Dr Lars Klinge
Dr Michelle Eagle
Professor Volker Straub
Emerita Professor Katherine Bushby
Severe phenotype in infantile facioscapulohumeral muscular dystrophy
2006
Dr Lars Klinge
Professor Volker Straub
Enzyme replacement therapy in classical infantile Pompe disease: Results of a ten-month follow-up study
2005
Dr Lars Klinge
Professor Volker Straub
Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial
2005